The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

Intensive Care Unit

Filter Newest Oldest Showing 1-7 of 7 results
Original Article / VOLUME 6, ISSUE 4, DECEMBER 2024

Impact of Needle-Free Connector and Prefilled Flushing Syringe Shortage on CLABSI Rates in Pediatric Intensive Care

İlker Devrim and others

The most common and serious complication of central venous catheter usage is central line–associated bloodstream infections (CLABSIs) in children and adults. Between 2011 and 2014, CLABSIs were the most frequently reported healthcare-associated illness among hospitals in the USA. Bloodstream infections associated with central lines are […] Read More

Original Article / VOLUME 6, ISSUE 4, DECEMBER 2024

Early Diagnosis of Candidemia in the Intensive Care Unit by Clinical and Molecular Methods: A Prospective Observational Study

Khalis Mustafayev and others

Invasive Candida infections have increased significantly in recent years due to various risk factors, including invasive procedures, vascular catheterization, intra-abdominal surgery, prolonged use of broad-spectrum antibiotics, immunosuppressive medications, hemodialysis, total parenteral nutrition (TPN), and extended intensive care unit (ICU) stays. Candida, one of the top three nosocomial bloodstream infections, [...] Read More

Original Article / VOLUME 5, ISSUE 2, JUNE 2023

The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19

Yeşim Yıldız and others

Vaccines to prevent SARS-CoV-2 infection are the most promising and effective approach to curb the COVID-19 pandemic, as well as to reduce hospitalizations and prevent mortality.  In our country, the CoronaVac (Sinovac Biotech, China) vaccine started to be administered as of January 13, 2021, and the Comirnaty (BNT162b2, Pfizer-BioNTech) vaccine as (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Thyroid Dysfunction among the Patients with Critical COVID-19

Hande Özportakal and others

The world has been fighting against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than two years, leading to more than 605 million cases and 6.4 million deaths as of September 11, 2022. Since the angiotensin-converting enzyme (ACE) is the functional receptor for SARS-CoV-2, predominantly expressed by the alveoli (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Prospective Evaluation of Infections in Geriatric Patients in Intensive Care Units

Hasan Naz and others

Nosocomial infections (NIs) constitute a major health issue in terms of morbidity, high mortality, prolonged hospitalization, and increased costs of direct patient care. While beds in intensive care units (ICUs) constitute less than 10% of all hospital beds, more than 20% of all NIs develop in the ICU. The human lifespan has been prolonged (...) Read More

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

Retrospective Evaluation of Risk Factors for Invasive Candida Infections in a Medical Intensive Care Unit

Mehmet Kürşat Bilgin and others

Fungal infections account for about 20% of all microbiological infections in critically ill patients. Candida species are the most common fungi in intensive care units (ICU) and mostly C. albicans. However, the rate of non-albicans Candida species such as C. tropicalis, C. krusei, C. parapsilosis, C. glabrata which are more resistant to antifungal therapy (...) Read More